David Owens - Jan 13, 2025 Form 4 Insider Report for Nexalin Technology, Inc. (NXL)

Role
Chief Medical Officer, Director
Signature
/s/ David Owens Name: David Owens, M.D.
Stock symbol
NXL
Transactions as of
Jan 13, 2025
Transactions value $
$7,700
Form type
4
Date filed
1/24/2025, 04:55 PM
Previous filing
Jan 29, 2025
Next filing
Jan 29, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXL Common stock Purchase $5K +2K +1.34% $2.50 151K Jan 13, 2025 Direct
transaction NXL Common stock Purchase $2.7K +1K +0.66% $2.70 152K Jan 23, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.